Skip to main content
Caplight Logo









CH-Bioforce Oy

CH-Bioforce Oy

Private
EspooFrontier & Industrial Techhttps://www.ch-bioforce.com/

Last Round

Grant

Jun 22, 2022

Total Funding Raised

$2.52M

Company Overview

CH-Bioforce Oy is a cleantech company that has developed a biomass fractionation technology to convert waste streams into complete bio-based materials like cellulose, lignin, and hemicellulose.

Sector

Frontier & Industrial Tech

Verticals

Sustainable Materials, Advanced Materials, Circular Economy, Clean Manufacturing, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

biomass fractionationbiomaterialssustainable materialsdissolving cellulosesulfur-free ligninhemicellulosetechnology licensingbiorefineryfossil-free materialscleantechwaste valorizationcircular economyindustrial biotechagricultural waste processingbio-based chemicalsbio-based textilesbio-based cosmetics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CH-Bioforce Oy Comparables

Compare CH-Bioforce Oy with similar companies based on industry and business-model similarity.

CH-Bioforce Oy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lixea
90%
Bloom Biorenewables
84%
CELLiCON
84%

CH-Bioforce Oy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 22, 2022
AcceleratorFeb 27, 2020
GrantMar 1, 2019

Key People

Founding team and executive leadership

Petri Tolonen

Chief Executive Officer

Executive Team

Tapani Niskanen

CEO

Executive Team

Nicholas Lax

Chief Technology Officer

Executive Team

CH-Bioforce Oy Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 40% MoM.

  • Dec 8, 2025

    Monthly visitors increased 31% MoM.

CH-Bioforce Oy Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CH-Bioforce Oy Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CH-Bioforce Oy's valuation, stock price, and market status.

Firmographic Details

HeadquartersEspoo
Employee Range11
Year Founded2016
Last FundingJun 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?